CDKN1A and lymphoma: In T-lymphomas, S-lymphomas, and sarcomas isolated from ATO-treated p53−/− mice, Cdkn1a or Mdm2 was not upregulated (Figure 1N), without signs of cell proliferation inhibition or cell apoptosis induction (Figures 1O and S1L).